Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.04 USD
Change Today 0.00 / 0.00%
Volume 0.0
QTXB On Other Exchanges
As of 8:10 PM 05/15/15 All times are local (Market data is delayed by at least 15 minutes).

quantrx biomedical corp (QTXB) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/30/14 - $0.09
52 Week Low
12/22/14 - $0.02
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

quantrx biomedical corp (QTXB) Related Businessweek News

No Related Businessweek News Found

quantrx biomedical corp (QTXB) Details

QuantRx Biomedical Corporation focuses on the development and commercialization of diagnostic products for the healthcare industry worldwide. The company offers PAD based products for the over-the-counter and laboratory markets based on its patented technology platforms; and its genomic diagnostics, based on its patented PadKit technology. Its product and product candidates include PADKit that contains a miniform used as a collection device to collect a sample for vaginal diagnostic evaluation for indications, such as HPV, human immunodeficiency virus, and general health screening; and Unique miniform, which is available as a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad, for the daily protection of light urinary, vaginal, or anal leakage. The company was incorporated in 1986 and is based in Tualatin, Oregon.

quantrx biomedical corp (QTXB) Top Compensated Officers

Chairman, Chief Executive Officer and Princip...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

quantrx biomedical corp (QTXB) Key Developments

QuantRx Biomedical Corporation announced delayed 10-Q filing

On 05/15/2015, QuantRx Biomedical Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

QuantRx Biomedical Corporation announced delayed annual 10-K filing

On 03/31/2015, QuantRx Biomedical Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.

QuantRx Biomedical Corporation Announces Demise of William Fleming, President, Chief Scientific Officer and Director

QuantRx Biomedical Corporation announced that William Fleming, its President, Chief Scientific Officer and a director, unexpectedly passed away on March 21, 2015. The Board of Directors is currently searching for a successor to manage the Company as it executes is business plan. In the interim, the company will be managed by its Chief Executive Officer, with assistance from its Board of Directors and outside advisors.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
QTXB:US $0.04 USD 0.00

QTXB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for QTXB.
View Industry Companies

Industry Analysis


Industry Average

Valuation QTXB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 813.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 293.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QUANTRX BIOMEDICAL CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at